Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

TransMedics (TMDX) Other Gross PP&E Adjustments (2018 - 2025)

Historic Other Gross PP&E Adjustments for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $364.1 million.

  • TransMedics' Other Gross PP&E Adjustments rose 1921.73% to $364.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $364.1 million, marking a year-over-year increase of 1921.73%. This contributed to the annual value of $317.8 million for FY2024, which is 7460.77% up from last year.
  • Per TransMedics' latest filing, its Other Gross PP&E Adjustments stood at $364.1 million for Q3 2025, which was up 1921.73% from $358.2 million recorded in Q2 2025.
  • TransMedics' Other Gross PP&E Adjustments' 5-year high stood at $364.1 million during Q3 2025, with a 5-year trough of -$8.3 million in Q2 2023.
  • Over the past 5 years, TransMedics' median Other Gross PP&E Adjustments value was $23.7 million (recorded in 2022), while the average stood at $131.5 million.
  • As far as peak fluctuations go, TransMedics' Other Gross PP&E Adjustments tumbled by 212730.38% in 2022, and later soared by 367152.47% in 2024.
  • TransMedics' Other Gross PP&E Adjustments (Quarter) stood at $11.5 million in 2021, then soared by 106.8% to $23.7 million in 2022, then skyrocketed by 666.89% to $182.0 million in 2023, then skyrocketed by 74.61% to $317.8 million in 2024, then grew by 14.59% to $364.1 million in 2025.
  • Its Other Gross PP&E Adjustments was $364.1 million in Q3 2025, compared to $358.2 million in Q2 2025 and $345.9 million in Q1 2025.